State of Wisconsin Investment Board
ATRA icon

State of Wisconsin Investment Board’s Atara Biotherapeutics ATRA Stock Holding History

State of Wisconsin Investment Board’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,812
Closed -$31.4K – 2307
2024
Q1 		$31.4K Buy
1,812
+4
+0.2% +$71 ﹤0.01% 2182
2023
Q4 		$23.2K Hold
1,808
– – ﹤0.01% 2324
2023
Q3 		$66.9K Hold
1,808
– – ﹤0.01% 2398
2023
Q2 		$72.8K Sell
1,808
-6,815
-79% -$385K ﹤0.01% 2239
2023
Q1 		$625K Sell
8,623
-3,809
-31% -$369K ﹤0.01% 1757
2022
Q4 		$1.02M Buy
12,432
+6,146
+98% +$640K ﹤0.01% 1497
2022
Q3 		$594K Buy
6,286
+1,226
+24% +$138K ﹤0.01% 1883
2022
Q2 		$985K Sell
5,060
-956
-16% -$156K ﹤0.01% 1646
2022
Q1 		$1.4M Hold
6,016
– – ﹤0.01% 1578
2021
Q4 		$2.37M Hold
6,016
– – ﹤0.01% 1238
2021
Q3 		$2.69M Hold
6,016
– – 0.01% 1219
2021
Q2 		$2.34M Hold
6,016
– – ﹤0.01% 1246
2021
Q1 		$2.16M Buy
6,016
+1,808
+43% +$799K ﹤0.01% 1222
2020
Q4 		$2.06M Sell
4,208
-1,284
-23% -$593K ﹤0.01% 1194
2020
Q3 		$1.78M Buy
5,492
+448
+9% +$153K ﹤0.01% 1176
2020
Q2 		$1.84M Buy
5,044
+1,404
+39% +$355K 0.01% 1143
2020
Q1 		$774K Buy
3,640
+976
+37% +$310K ﹤0.01% 1249
2019
Q4 		$1.1M Hold
2,664
– – ﹤0.01% 1219
2019
Q3 		$940K Buy
2,664
+228
+9% +$85.1K ﹤0.01% 1160
2019
Q2 		$1.23M Buy
2,436
+128
+6% +$90.3K ﹤0.01% 1091
2019
Q1 		$2.29M Buy
2,308
+576
+33% +$535K 0.01% 976
2018
Q4 		$1.5M Buy
1,732
+76
+5% +$70.6K ﹤0.01% 1022
2018
Q3 		$1.71M Hold
1,656
– – ﹤0.01% 1067
2018
Q2 		$1.52M Buy
1,656
+580
+54% +$623K ﹤0.01% 1044
2018
Q1 		$1.05M Buy
1,076
+356
+49% +$324K ﹤0.01% 1121
2017
Q4 		$326K Hold
720
– – ﹤0.01% 1352
2017
Q3 		$298K Hold
720
– – ﹤0.01% 1372
2017
Q2 		$252K Buy
+720
New +$277K ﹤0.01% 1380

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State of Wisconsin Investment Board's ATRA Position: Q2 2024 in Review

State of Wisconsin Investment Board sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 1,812 shares — an estimated $31.4K sold.

State of Wisconsin Investment Board first reported a position in ATRA in Q2 2017 and held it in 28 quarters. The position peaked at $2.69M in Q3 2021. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • State of Wisconsin Investment Board reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,812 Atara Biotherapeutics shares in Q2 2024, an estimated $31.4K.
  • State of Wisconsin Investment Board first reported a position in Atara Biotherapeutics in Q2 2017 and held it in 28 quarters.
  • State of Wisconsin Investment Board's Atara Biotherapeutics position peaked at $2.69M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2024, filed 14 Aug 2024.